Uncategorized
NovaBay Pharmaceuticals Reports 2019 Second Quarter Financial Results
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova for the domestic eye care market, reports financial results for the three and six months ended June 30, 2019 and provides a business update. “We are having success with our strategy to increase Avenova sales through various channels that address the negative impact of high-deductible health plans on unit sales and gross-to-net revenue,” said J